AI assistant
Sending…
CERUS CORP — Director's Dealing 2014
Apr 4, 2014
33349_dirs_2014-04-04_464faa19-879c-4079-b871-fbdc4c46fb8a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CERUS CORP (CERS)
CIK: 0001020214
Period of Report: 2013-11-08
Reporting Person: CORASH LAURENCE M (Director, Chief Med & Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-08 | Common Stock | M | 34000 | $4.25 | Acquired | 605756 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-08 | Otion (Right to Buy) | $4.25 | M | 34000 | Disposed | 2013-12-08 | Common Stock (34000) | Direct |
Footnotes
F1: The option vested in equal monthly installments over 48 months from November 14, 2003.
F2: Not applicable.
More from CERUS CORP
Interim / Quarterly Report
2026
Apr 30
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Mar 24
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Jan 23
Regulatory Filings
2026
Jan 12
Director's Dealing
2025
Nov 26